Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder

BACKGROUND: Buprenorphine-naloxone is an evidence-based treatment for Opioid Use Disorder. However, despite its efficacy, nearly half of participants are unsuccessful in achieving stabilization (i.e., period of time following medication induction in which medication dose is adjusted to be effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Langdon, Kirsten J., Ramsey, Susan, Scherzer, Caroline, Carey, Kate, Ranney, Megan L., Rich, Josiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191734/
https://www.ncbi.nlm.nih.gov/pubmed/32349790
http://dx.doi.org/10.1186/s13722-020-00189-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191734/
https://www.ncbi.nlm.nih.gov/pubmed/32349790
http://dx.doi.org/10.1186/s13722-020-00189-4

Ejemplares similares